Fundings

  1. Project Title: Skeletal role of CK2-interating Protein-1 in Regulating Osteoblastic Bone Formation: Molecular Mechanism and Reversing Osteoporosis
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Research Grants Council & Natural Science Foundation Council
    3. Project ID: N_HKBU435/12
    4. Exercise Year: 2012/2013
    5. Approved Project Duration: 48 months
    6. Project Fund: HK$ 753,925
  2. Project Title: Study on molecular mechanism of bone formation reduction in aged women: Functional role of CKIP-1
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Natural Science Foundation Council
    3. Project ID: NSFC
    4. Exercise Year: 2012/2013
    5. Approved Project Duration: 36 months
    6. Project Fund: RMB$700,000.00
  3. Project Title: Toward a novel bone anabolic strategy for aged postmenopausal osteoporosis: Inhibiting miR-214 in osteogenic cells for promoting bone formation
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund
    3. Project ID: 478312
    4. Exercise Year: 2012/2013
    5. Approved Project Duration: 30 months
    6. Project Fund: HK$950,000.00
  4. Project Title: Therapeutic RNAi targeting CKIP-1 to reverse severe postmenopausal osteoporosis
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund
    3. Project ID: 479111
    4. Exercise Year: 2011/2012
    5. Approved Project Duration: 24 months
    6. Project Fund: HK$920,000.00
  5. Project Title: Toward leading role in RNA interference-based translational approach to address orthopedic challenges in Hong Kong: Targets and Therapeutics
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Committee of Focused Investments Scheme ĘC Scheme B: High Promise Initiatives in The Chinese University of Hong Kong
    3. Project ID: 1902063
    4. Exercise Year: 2010/2011
    5. Approved Project Duration: 24 months
    6. Project Fund: HK$1500,000.00
  6. Project Title: Promoting osteoporotic fracture repair: Role of estrogen receptor beta pathway blockade
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Switzerland AO Research Grant of the AO Foundation
    3. Project ID: S0874Z
    4. Exercise Year: 2008/2009
    5. Approved Project Duration: 36 months
    6. Project Fund: CHF120,000
  7. Project Title: A Novel Selective-Estrogen-Receptor-Modulator Developed for Treatment of Osteoporosis in Cortical Bone of Ovariectomized Rat
    1. Principle Investigator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund
    3. Project ID: 478508
    4. Exercise Year: 2007/2008
    5. Approved Project Duration: 30 months
    6. Project Fund: HK$624,365.00
  8. Project Title: Blockade of VEGF-Src signaling as a novel therapeutic strategy to prevent destructive repair in steroid-associated osteonecrosis
    1. Executive Investigator / Coordinator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund
    3. Project ID: CUHK473011
    4. Exercise Year: 2011/2012
    5. Approved Project Duration: 24 months
    6. Project Fund: HK$862,500.00
  9. Project Title: Towards reconstruction of functional neovasculature for repairing steroid-associated osteonecrosis lesion: A strategy by implanting autologous marrow-mononuclear-cell cryopreserved prior to pulsed steroid-administration
    1. Executive Investigator / Coordinator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund
    3. Project ID: CUHK 472508
    4. Exercise Year: 2007/2008
    5. Approved Project Duration: 24 months
    6. Project Fund: HK$809,573.00
  10. Project Title: Icaritin, an estrogenic compound purified from herbal Epimedium, developed for prevention of steroid-induced osteonecrosis through a unique mechanism by inhibiting both intravascular thrombosis and extravascular lipid-deposit
    1. Executive Investigator / Coordinator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund
    3. Project ID: CUHK 4503/06M
    4. Exercise Year: 2006/2007
    5. Approved Project Duration: 24 months
    6. Project Fund: HK$740,000.00
  11. Project Title: Epimedium-derived Flavonoids Reduce Risk of Steroid-associated Osteonecrosis: A Mechanistic Study from A Viewpoint of Chemistry Metabolism
    1. Executive Investigator / Coordinator: Dr. Ge Zhang
    2. Funding Body:Hong Kong General Research Fund- National Natural Science Foundation of China
    3. Project ID: CUHK405/08
    4. Exercise Year: 2007/2008
    5. Approved Project Duration: 24 months
    6. Project Fund: HK$445,000.00